Adenosine Deaminase Acting on RNA 1 (ADAR1) is an RNA-editing enzyme that converts adenosine to inosine, following RNA transcription. ADAR1's essential role in embryonic development, especially within the hematopoietic lineage, has been demonstrated in knockout mice. However, a specific role for ADAR1 in adult hematopoietic progenitor cells (HPCs) remains elusive. In this report, we show that ADAR1 is required for survival of differentiating HPCs as opposed to more primitive cells in adult mice by multiple strategies targeting floxed ADAR1 for deletion by Cre recombinase. As a consequence, ADAR1-deficient hematopoietic stem cells (HSCs) were incapable of reconstituting irradiated recipients although being phenotypically present in the recipient bone marrow. While an effect on HSCs cannot be completely ruled out, the preferential effect of ADAR1 absence on HPCs over more primitive hematopoietic cells was consistent with the increased expression of ADAR1 within HPCs, as well as the inability of ADAR1-deficient HPCs to form differentiated colonies and increased apoptotic fraction during ex vivo culture. Moreover, we have obtained direct evidence that ADAR1 functions in HPCs via an RNAediting dependent mechanism. Therefore, ADAR1 plays an essential role in adult hematopoiesis through its RNA editing activity in HPCs.
H
ierarchical hematopoiesis is a highly regulated process in which hematopoietic stem cells (HSCs) symmetrically or asymmetrically differentiate into hematopoietic progenitor cells (HPCs) that are directly responsible for the production of all lineages within the blood (1) . The balance between HSCs and HPCs depends on the developmental stage, age, as well as physiological and pathological conditions of the organism. Distinct molecular programs in HSCs as opposed to HPCs are the key to maintenance of homeostasis within the hematopoietic cascade and their disruption may contribute to pathological states, such as leukemogenesis. However, few molecules have been clearly demonstrated to have distinct roles in HSCs versus HPCs.
RNA editing recodes RNA molecules thereby posttranscriptionally regulating gene function in eukaryotic cells (2, 3) . As the enzymes responsible for one type of RNA editing, the adenosine deaminases acting on RNA (ADAR) convert adenosine (A) residues to inosine (I) specifically on double-stranded RNAs thereby generating RNA molecules not encoded in the genome (4) . Of the three members of the ADAR family in mammals (5) , disruption of ADAR1 in mice leads to embryonic lethality, likely due to defective hematopoiesis in the fetal liver (6) (7) (8) . Because ADAR1 Ϫ/Ϫ embryos die at 11-12 days post coitus, it was not possible to define the role of ADAR1 during and after definitive hematopoiesis in these mice. A recent study confirmed the previous finding of dysregulated hematopoiesis within the fetal liver, as well as adult bone marrow by ADAR1-deficient cells (9) . However, the cellular mechanism underlying this phenomenon remains elusive, in particular the role of ADAR1 in HPCs as opposed to HSCs. By conditional deletion of floxed ADAR1 alleles we have demonstrated the inability of ADAR1-deficient HSCs to reconstitute irradiated recipient bone marrow despite their engraftment in the bone marrow. ADAR1-deficient HPCs failed to form differentiated colonies ex vivo, most likely due to increased apoptosis within these cells and a lack of ADAR1's RNA editing activity. HPCs are therefore dependent on ADAR1 for their survival and function during adult hematopoiesis.
Results
Conditional Deletion of ADAR1 in Hematopoietic Cells. To determine the efficiency and functional consequence of ADAR1 deletion by Cre recombinase, hematopoietic cells isolated from 16-week old mice harboring floxed ADAR1 alleles (ADAR1 lox/lox ) (8) were transduced with a Murine Stem Cell Virus (MSCV) (10) carrying Cre and GFP (MSCV-Cre) or GFP alone (MSCV) ( Fig. 1 B and C) . PCR confirmed efficient deletion of ADAR1 lox/lox alleles in hematopoietic cells transduced with MSCV-Cre (ADAR1 ⌬/⌬) (Fig. 1D) . Moreover, 82% of single sorted HSC-enriched GFP ϩ Lineage Ϫ cKit ϩ Sca-1 ϩ (LKS ϩ ) cells isolated by micromanipulation were found to be ADAR1 ⌬/⌬ as early as 24 to 30 h after MSCV-Cre transduction (Fig. 1E ). To functionally validate ADAR1 deletion in hematopoietic cells, in vitro proliferation of transduced Lin Ϫ bone marrow cells was measured. While the total cell number in the ADAR1 lox/lox group increased 5-fold over 1 week of culture, ADAR1 ⌬/⌬ cells decreased in number by 75% within the first 4 days of culture (Fig. 1F ) similar to the results observed in previous studies (6, 9) . Thus retroviral delivery of Cre recombinase efficiently deleted ADAR1 in hematopoietic cells.
Lack of Hematopoietic Reconstitution but Preservation of Phenotypic
HSCs in ADAR1 ⌬/⌬ Transplant Recipients. To study the specific role of ADAR1 in HSCs versus HPCs, the in vivo reconstituting ability of ADAR1 ⌬/⌬ cells was determined by transplantation into irradiated NOD.Cg-Prkdc scid IL2rg tm1Wjl /SzJ (NOD/SCID␥c null ) (11) mice due to the mixed background of the ADAR1 lox/ lox mice and unavailability of a congenic strain. One hundred thousand to 1.5 ϫ 10 5 GFP ϩ ADAR1 ⌬/⌬ or ADAR1 lox/lox bone marrow cells were transplanted into sublethally irradiated (3.5 Gy) NOD/SCID-␥c null recipients and multilineage engraftment in the peripheral blood was monitored for up to 3 months. NOD/SCID-␥c null mice transplanted with ADAR1 lox/lox cells transduced with MSCV or wild-type cells transduced with MSCV-Cre were used as controls. While control cells expressing ADAR1 were able to reconstitute up to 90% of the peripheral blood in transplant recipients ( Fig. 2 A and B) , engraftment of ADAR1 ⌬/⌬ cells was less than 1% in all host mice (Fig. 2 A) . Engraftment levels in the thymus and spleen were consistent Author contributions: R.X., H.S., Q.W., and T.C. designed research; R.X., M.J.B., H.S., Y.L., H.Y., Y.G., and Q.Y. performed research; H.S. contributed new reagents/analytic tools; R.X., Q.W., and T.C. analyzed data; and R.X., M.J.B., Q.W., and T.C. wrote the paper.
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with that of the peripheral blood (Table S1 ). Flow cytometric analysis of the blood (Fig. 2C ) and flow and histological studies of the spleen (Fig. S1 ) showed an absence of ADAR1 ⌬/⌬ cells in the periphery. Bone marrow engraftment was significantly higher in control recipients compared to ADAR1 ⌬/⌬ recipients, in which the donor-derived cells were less than 0.1% (Fig. 2 D and E and Table S1 ). A defect in HSC homing was not observed as CFSE-labeled ADAR1
⌬/⌬ cells were present in the bone marrow 1 day following transplantation (Fig. S2) .
Interestingly, within this small population of donor-derived cells in the bone marrow of ADAR1 ⌬/⌬ recipients, the percentage of HSC-enriched LKS ϩ cells was more than 40-fold higher than that in control recipients (Fig. 2 F and G) . However, the absolute number of LKS ϩ cells was not statistically different between the two groups (Fig. 2H) . A similar lack of hematopoietic reconstitution despite the presence of phenotypically-defined HSCs in the bone marrow was observed when HSC-enriched ADAR1 ⌬/⌬ LKS ϩ cells were transplanted into irradiated recipients (Fig. S3) .
Given that the LKS phenotype becomes less reliable for HSC identification in transplant recipients (12) lox/lox or ER-Cre-ADAR1 lox/wild mice as a control were sorted and transplanted into 10-Gy irradiated C57/BL6 recipients together with 100,000 competitor cells (CD45.2). Three months after transplantation, floxed ADAR1 alleles were deleted by oral administration of tamoxifen. One month later, peripheral blood engraftment in ER-Cre-ADAR1 lox/lox recipients was significantly decreased compared to mice transplanted with ER-Cre-ADAR1 lox/wild cells (Fig. S4 ) similar to the engraftment observed with ADAR1 lox/lox hematopoietic cells transduced with MSCV-Cre ( Fig. 2A) . Six months after ADAR1 deletion, the recipients were killed and a 22 to 240-fold increase in the frequency of SLAM (Lin Ϫ CD48 Ϫ CD150 ϩ ) donorderived HSCs in the bone marrow was observed even though the overall bone marrow engraftment was Ͻ1% in ER-Cre-ADAR1 lox/lox recipients ( Fig. 2 I and J) . Consistent with ADAR1
⌬/⌬ transplant recipients (Fig. 2H) , an almost identical absolute number of donor-derived SLAM HSCs in the bone marrow of ER-Cre-ADAR1 lox/lox and ERCre-ADAR1 lox/wt recipient groups was found (Fig. 2K ). Together, this in vivo data from distinct gene deletion strategies and HSC phenotypes strongly suggest that ADAR1-deficient HSCs engrafted and were sustained in the bone marrow although the production or maintenance of mature blood cells in the recipients was disrupted.
A Selective Effect of ADAR1 Absence on HPCs Versus More Primitive
Cells. To understand the observed preferential dependence of HSC progeny rather than HSCs themselves on ADAR1 following transplantation, the expression of ADAR1 in hematopoietic cells at different stages of maturation was determined by realtime RT-PCR. ADAR1 expression was relatively low in more primitive HSCs (CD34 Ϫ LKS ϩ ) and mature bone marrow populations as compared to progenitor cell types (Fig. 3A) . Increased expression of ADAR1 at the protein level in HPCs by intracellular staining analyzed by flow cytometry (Fig. S5 ) further suggested a preferential role of ADAR1 within HPCs.
To define this association functionally, sorted Lin Ϫ c-Kit ϩ bone marrow cells were transduced with MSCV-Cre or MSCV and single HSC enriched GFP ϩ LKS ϩ cells were sorted and deposited into Terasaki plates by micromanipulation. Similar proliferative rates were observed in ADAR1 ⌬/⌬ and ADAR1 lox/lox LKS ϩ cells within the first 72 h of culture (Table 1 ). In contrast, there was limited growth of the HSC-depleted and HPC-enriched Lin Ϫ c-Kit (17) upon ADAR1 deletion during 3 days of liquid culture (Fig. 3B) , a result similar to that found with the previous data derived from liquid culture of total GFP ϩ cells following transduction (Fig. 1F) . Assessment of the in vitro proliferation of ER-Cre-ADAR1 lox/lox cells following tamoxifen induction of Cre expression confirmed the selective adverse effect of ADAR1 absence on LKS Ϫ cells over more primitive LKS ϩ cells (Fig. S6) . Furthermore, an equal number of sorted ADAR1 ⌬/⌬ or ADAR1 lox/lox LKS Ϫ HPCs were seeded into semisolid methylcellulose medium, and the number of colonies examined after 7 days of culture. ADAR1 ⌬/⌬ LKS Ϫ cells yielded a strikingly lower number of colonies, as compared to ADAR1 lox/lox LKS Ϫ cells (Fig. 3C ). Most colonies formed in the ADAR1 ⌬/⌬ group were tiny and of an atypical morphology (Fig. 3D ). Those atypical colonies were picked, cytospun, and stained with May-Grunward/Giemsa. The cells compromising the colony were also small and atypical in morphology, as compared to the multilineage differentiated cells in the ADAR1 lox/lox group (Fig. 3E) which suggests that the progenitor cells were able to proliferate at the beginning and then underwent apoptosis during culture.
Increased Apoptosis of Differentiating HPCs Following ADAR1 Deletion. Our previous studies demonstrated that apoptosis is the primary cellular mechanism underlying the embryonic lethality of ADAR1 Ϫ/Ϫ mice (6, 8) . To determine whether apoptosis could explain the decrease in colony formation upon ADAR1 deletion (Fig. 3C) and absence of peripheral engraftment in ADAR1 ⌬/⌬ reconstituted mice, ADAR1 lox/lox bone marrow cells were transduced with MSCV or MSCV-Cre and cultured for 4 days. The number of Lin ϩ cells diminished rapidly in the absence of ADAR1, whereas it continuously expanded in the ADAR1 lox/ lox group during culture (Fig. 3F) . In contrast, the absolute number of more primitive Lin Ϫ ScaI ϩ ADAR1 ⌬/⌬ cells was relatively steady during the culture period (Fig. 3F ) and the percentage of Lin Ϫ ScaI ϩ cells was not significantly different between the ADAR lox/lox and ADAR1 ⌬/⌬ groups (Fig. 3G) . Apoptosis was measured at the end of 4 days of culture by a Terminal uridine deoxynucleotidyl transferase Nick End Labeling (TUNEL) assay. As compared to ADAR1 lox/lox cells, ADAR1
⌬/⌬ Lin ϩ cells exhibited a 10-fold increase in apoptosis, while more primitive Lin Ϫ cells only showed a slight increase in the percentage of apoptotic cells (Fig. 3 H and I ). An increased rate of apoptosis in the differentiated cells was confirmed by Annexin V staining (Fig. S7) . Furthermore, senescence was unlikely involved due to equivalent ␤-galactosidase staining in both Lin-and Linϩ populations of cells (Fig. S8) . Therefore, an increase in apoptosis rather than senescence was largely responsible for the decrease of differentiating HPCs following ADAR1 deletion during culture and likely underlies the decreased colony formation and in vivo engraftment of ADAR1-deficient cells.
ADAR1 Functions in Hematopoietic Cells via Its RNA Editing Domain.
ADAR1 consists of a catalytic RNA editing domain, as well as RNA and Z-DNA binding domains, which are believed to mediate different functions of ADAR1 (8) . To determine whether the RNA editing activity of ADAR1 is necessary for its function in hematopoietic cells, the ability of an MSCV-delivered wild type or mutant ADAR1 lacking RNA editing activity (Fig. 4A ) to rescue the colony forming ability of ER-Cre-ADAR1 ⌬/⌬ HPCs was determined (Fig. 4B) . duced wild-type ADAR1 (p150) rescued more than half of the colony forming ability of HPCs. There were significantly fewer colonies generated from cells transduced with ADAR1 (E/A) harboring a point mutation in its RNA editing catalytic site. The morphology of colonies generated from cells without ADAR1 or expressing E/A was similar to those generated by ADAR1 ⌬/⌬ (compare Figs. 3D and 4D ). This demonstrates that the role of ADAR1 in HPCs is largely dependent on its RNA editing function.
Discussion
Our current study demonstrates a relatively selective effect of ADAR1 deletion in HPCs as compared to HSCs. Unlike some hematopoietic transcription factors such as MLL, SCL, and RUNX1 (18) (19) (20) , ADAR1 is required for adult, but not primitive embryonic hematopoiesis and is more critical for differentiating HPCs, as opposed to more primitive HSCs or mature blood cells.
This data, taken together with the fact that the growth of neither embryonic stem (ES) cells (7, 8) nor differentiated fibroblastic cells, (8, 21) appear to require ADAR1 (Fig. S9) suggests that the survival of differentiating progenitor cells such as HPCs may be more dependent on ADAR1 than other cell types. While we have evidence indicating that increased apoptosis may underlie the selective effect of ADAR1 deletion on differentiating HPCs, we could not formally exclude direct effects of ADAR1 on other functions of HSCs such as self renewal. However, given the equivalence of HSC numbers following transplantation of ADAR1 lox/lox and ADAR1 ⌬/⌬ cells (Fig. 2 H and K) and efficient homing of ADAR1 ⌬/⌬ cells (Fig. S2) , it seems unlikely that ADAR1 plays an indispensable role in HSCs.
This work contrasts a recently published paper by Hartner et al. (9) claiming that ADAR1 is an essential regulator of HSC maintenance. In Hartner's work (9), there was no definitive evidence for the effect of ADAR1 on HSCs perhaps due to the fact that the authors failed to demonstrate successful deletion of ADAR1 in the analyzed cell populations in the conditional gene-deletion model, thereby jeopardizing their conclusions regarding the cellular mechanism of ADAR1. In fact, increased HSC abundance in ADAR1-null fetal liver shown in their study would support our current claim that ADAR1 is more essential in HPCs than HSCs (9) . In contrast, we have direct evidence for efficient gene deletion in the cell population (Fig. 1D) as well as at the single cell level (Fig. 1E) . Based on this important prerequisite, we have multiple lines of compelling evidence consistently demonstrating a selective effect of ADAR1 on differentiating progenitor cells over more primitive cells, that is dependent on its RNA editing function.
As one of the RNA processing mechanisms, adenosine to inosine RNA editing regulates gene activity through modification of mRNA (22, 23) noncoding RNA (24, 25) , and regulatory small RNAs (e.g., microRNAs) (21, (26) (27) (28) . The RNAs that code critical hematopoietic regulators, or the regulatory RNAs themselves, may require ADAR1-mediated editing before their physiological actions in these cells. Therefore, defining the targets of ADAR1 in Single sorted GFP ϩ Lin -Sca-1 ϩ cells were picked and deposited into Terasaki plates by micromanipulation, and cell division was monitored daily for up to 1 week. Initially, 144 cells were input at specific time point for each group. The number in the table indicates the wells containing live cells (first column) or accumulative wells with cell divisions. There was no statistical significance among groups in terms of survival and division rates according to Chi-Square test (P Ͼ 0.05). differentiating hematopoietic cells will likely reveal a class of molecules that are critical for hematopoietic regeneration and perhaps also relevant for studies concerning leukemia or other hematopoietic disorders.
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Materials and Methods
Mice. ADAR1 lox/lox mice in a C57BL/6 and FVB mixed background were generated in our previous study (8) . B6.Cg-Tg(CAG-cre/Esr1)5Amc/J (ER-Cre) mice were purchased from Jackson Laboratory and crossed to our ADAR1 lox/lox mice which were bred inhouse. Excision of floxed ADAR1 alleles in ER-Cre-ADAR1 lox/lox mice was accomplished by oral administration of 0.2 mg/g tamoxifen in 0.2 to 0.3 mL vegetable oil daily for 3 days. NOD.Cg-PrkdcscidIL2rgtm1Wjl/SzJ (NOD/SCID␥c null ) mice were bred in the animal facility at University of Pittsburgh Cancer Institute. All mice were handled in accordance to institutional guidelines for animal care. Flow Cytometry and Cell Sorting. Cultured and freshly harvested bone marrow nucleated cells were stained with lineage (CD3, CD4, CD8, CD11b, CD45R, Gr-1, and Ter119), Sca-1, and/or CD45.1, CD45.2 (BD PharMingen) surface markers and examined by flow cytometry as previously described (17) .
Retroviral
CFC Assay. GFP ϩ Lin Ϫ Sca-1 Ϫ cells were sorted 24 h after transduction, resuspended in semisolid methylcellulose medium M3434 (StemCell Technologies), and plated in triplicate in 24-well plates at 4,000 cells/well. The cells were cultured at 37°C, 5% CO 2 for up to 14 days and colonies counted after 7-11 days in culture.
TUNEL Staining. Forty-eight hours after transduction, GFP ϩ Lin Ϫ and GFP ϩ Lin ϩ cell populations were sorted and 10,000 -40,000 cells were immediately attached to glass slides by cytospin. Slides were stained with the In Situ Cell Death Detection Kit, TMR Red (Roche), followed by nuclear staining with 5 g/L DAPI (Sigma) per the manufacturer's instructions. Fluorescent images were taken immediately after staining and positive and total cell numbers were counted for more than 3 fields, or 200 to 300 cells, per slide.
Hematopoietic Cell and HSC Transplantation. Six hours before transplantation, 6-to 8-week-old recipient NOD/SCID-␥c null mice were sublethally (3.5 Gy, 82 cGy/ min, 137 Cs ␥ radiator) irradiated. 1.0 to 1.5 ϫ 10 5 transduced GFP ϩ Lin Ϫ or GFP ϩ Lin Ϫ Sca-1 ϩ cells were sorted and injected into the tail veins of recipients. Recipient mice were supplied with sterile food and acidified water. Multilineage engraftment in peripheral blood was monitored monthly for 3 months by flow cytometry.
Real-Time RT-PCR.
Five thousand hematopoietic cells from 6-to 8-week-old C57/Bl6 mice were directly sorted into cell lysis buffer and the RNA was extracted using Absolute RNA extraction kits (STRATAGENE) according to the manufacturer's instruction. cDNA was synthesized using SuperScript III (Invitrogen) and real-time RT-PCR was performed using Dynamo SYBR green qPCR kit (Finnzymes) on a PTC-200 thermo cycler (MJ Research) as previously described (6).
May-Grunwald/Giemsa Staining. Cytospin slides were stained with MayGrunwald and Giemsa (Sigma) according to the manufacturer's instructions.
